What is OmegaQuant?
OmegaQuant operates as an independent laboratory focused on providing advanced nutritional analytics, with a particular emphasis on omega-3 fatty acids. The company offers a suite of tests, including the widely recognized Omega-3 Index, designed for individuals, expectant mothers, and even pets. These analyses measure crucial fatty acids like EPA and DHA in blood samples, offering vital insights into an individual's omega-3 status. OmegaQuant serves a diverse clientele, including healthcare professionals, academic researchers, and health-conscious consumers, all seeking to leverage this data for improved health outcomes. The company also actively engages in disseminating knowledge through educational resources and collaborative research initiatives within the omega-3 nutrition sector.
How much funding has OmegaQuant raised?
OmegaQuant has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in OmegaQuant
PPP
Public-Private Partnership
What's next for OmegaQuant?
The substantial large-scale late-stage funding indicates OmegaQuant is poised for significant growth and market penetration. This strategic capital is likely to be deployed towards enhancing laboratory capabilities, expanding research and development into new nutritional markers, and broadening its service offerings to a global audience. Further strategic partnerships and potential acquisitions may also be on the horizon as the company solidifies its leadership in the specialized field of omega-3 analytics and nutritional diagnostics.
See full OmegaQuant company page
